Per E Lønning. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Hormonal/adverse effectsAromatase Inhibitors/adverse effectsBone Density/drug effectsBreast Neoplasms/drug therapyDenosumabFemaleHumansOsteoporosis/chemically inducedOsteoporosis/prevention & controlRANK Ligand/therapeutic useReceptor Activator of Nuclear Factor-kappa B/drug effects
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic Agents, HormonalAromatase InhibitorsRANK LigandReceptor Activator of Nuclear Factor-kappa BTNFRSF11A protein, humanDenosumab
Year: 2008 PMID： 18725646 DOI： 10.1200/JCO.2008.18.0851
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544